Noninvasive prenatal Screening

Different NIPS (NIPT) for different patient needs

No other genetic testing laboratory currently offers as much expertise, experience, and choice in NIPS (NIPT)—noninvasive prenatal screening, also called cfDNA (cell-free DNA) screening.

With the 2016 acquisition of Sequenom, creator of the first commercially available NIPS (NIPT), Integrated Genetics now offers two NIPSs  (NIPTs)—with more than 1 million tests run in total.

Each NIPS (NIPT) offers different capabilities and/or panels to suit the specific needs of your patients and your practice.

NIPS(NIPT) options

 MaterniT® GENOMEMaterniT®21 PLUS
Detects trisomy 21 (Down syndrome)
Yes
Yes
Detects trisomy 18 (Edwards syndrome)
Yes
Yes
Detects trisomy 13 (Patau syndrome)
Yes
Yes
Detects sex chromosome abnormalities*
Yes
Yes
Reports fetal fraction
Yes
Yes
Reports fetal sex*
Yes
Yes
Multiple gestations† 
Yes
Detects additional trisomies 22, 16*
Yes
Yes
Detects select microdeletions, such as 22q11.2 (DiGeorge syndrome)**
Yes
Yes
Performed as early as 9 weeks
Yes
Yes
~5 calendar day turnaround time
Yes
Yes
Genome-wide analysis of all chromosomes
Yes
 
Reports on any trisomy or monosomy
Yes
 
Detects subchromosomal abnormalities ≥ 7 Mb
Yes
 
 

Learn More

Learn More

MaterniT 21 PLUS and MaterniT GENOME,  are laboratory-developed test developed and performed exclusively by Integrated Genetics. 

* Optional reporting       ** Optional reporting for MaterniT 21 PLUS

MaterniT specimen collection kit

Upgraded MaterniT specimen collection kit

The upgraded MaterniT specimen collection kit features new branding for better kit identification and fewer components – including one 10 mL Streck tube instead of two – for improved ease-of-use.

Additional Resources